Form 4 for GNTX GENTEX CORP
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-02 · accession 0001562180-23-000877 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-02 | GNTX | Downing Steven R | Pres, CEO | S - Sale+OE | $30.21 | -17.7K | 118.5K | -13% | -$535.6K |
| D | 2023-02-03 | 2023-02-02 | GNTX | Downing Steven R | Pres, CEO | M - OptEx | $14.70 | +17.7K | 136.2K | +15% | +$260.6K |
| D | 2023-02-03 | 2023-02-02 | GNTX | Downing Steven R | Pres, CEO | M - OptEx | $0.00 | -17.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | S | D | 17,730 | $30.21 | 118,506 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. (F2) This transaction was executed in multiple trades at prices ranging from $30.00 to $30.39. The price reported above reflects the weighted average price. |
| 2 | Common | Common Stock | 2023-02-02 | M | A | 17,730 | $14.70 | 136,236 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to buy) | 2023-02-02 | M | D | 17,730 | $0.00 | 0 | D | $14.70 · 2017-02-22 to 2023-02-22 | 17,730 Common Stock | (F3) These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date. |